Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Myriad Genetics (MYGN) over the last 15 years, with Q2 2025 value amounting to $600000.0.

  • Myriad Genetics' Exchange Rate Effect rose 18571.43% to $600000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $1.2 million, marking a year-over-year increase of 18571.43%. This contributed to the annual value of -$1.0 million for FY2024, which is 26666.67% down from last year.
  • Latest data reveals that Myriad Genetics reported Exchange Rate Effect of $600000.0 as of Q2 2025, which was up 18571.43% from $100000.0 recorded in Q1 2025.
  • In the past 5 years, Myriad Genetics' Exchange Rate Effect ranged from a high of $1.2 million in Q3 2024 and a low of -$800000.0 during Q1 2024
  • Its 5-year average for Exchange Rate Effect is -$50000.0, with a median of -$50000.0 in 2021.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first surged by 60000.0% in 2022, then tumbled by 50000.0% in 2024.
  • Over the past 5 years, Myriad Genetics' Exchange Rate Effect (Quarter) stood at $100000.0 in 2021, then skyrocketed by 600.0% to $700000.0 in 2022, then changed by 0.0% to $700000.0 in 2023, then tumbled by 200.0% to -$700000.0 in 2024, then skyrocketed by 185.71% to $600000.0 in 2025.
  • Its last three reported values are $600000.0 in Q2 2025, $100000.0 for Q1 2025, and -$700000.0 during Q4 2024.